Dr Graeme Jarvis
General Manager, Medicines New Zealand, Wellington, NZ
Dr Graeme Jarvis has spent 25 years in a variety of research, management and international business development roles in the public and private sectors associated with the food and beverage, biotechnology and pharmaceutical sectors. This has included management positions at companies including the Lactose Company of New Zealand Ltd (now DMV-Fonterra Excipients Ltd) and ViaLactia Biosciences Limited. He has also been a key account and business development manager at NZTE where he was tasked with assisting New Zealand’s pharmaceutical and biotechnology companies export their products and services globally. He is an Adjunct Lecturer at Victoria University–Wellington where he has run under- and post-graduate biotechnology lecture courses on the commercialisation of biotechnology products. Since 2015, he has been the General Manager at Medicines New Zealand- the industry association representing companies engaged in the research, development, manufacture and marketing of modern prescription medicines.
Growing the Clinical Trials Ecosystem in New Zealand: Fact, Fiction or Folly?
Globally the clinical trials sector is both robust and is evolving along with many of the technologies that must go through this critical activity as part of their development and commercialisation processes. New Zealand has as a country initiated both internal discussions and action plans on this sector over the past decade. These have generally been with a focus on the opportunities for improved health sector outcomes and wider potential economic benefits. There are a number of questions and issues that still remain however, including: How can the country compete to attract or enhance its reputation as a participant in this global activity in order to grow the New Zealand economic pie? How big is the beneficial economic impact of clinical trials now and how big could it be? And what are our significant, bona fide, points of difference that will attract sponsors to undertake trials here, compared to other countries? This presentation aims to provide context on the New Zealand clinical trials ecosystem as it exists currently. It will also provide perspectives on some of the potential issues that both the clinical trials sector and country may have to overcome if they are to nurture and grow the clinical trials ecosystem into the future.